Introduction
Methotrexate and other antifolates are among the most effective and widely used drugs for the treatment of cancer and methotrexate remains the cornerstone of curative treatment for childhood leukemia (Pui and Evans, 1998) . Novel antifolates, including raltitrexed, ZD9331 and pemetrexed, have shown promise in treating a variety of cancers (Cocconi et al., 1998; Goh et al., 2001; Rusthoven et al., 1999) . Even after 50 years of use, questions remain regarding methotrexate's nephrotoxicity and renal elimination. Some studies have shown that methotrexate is secreted by the kidney (Monjanel et al., 1979) and other studies have shown methotrexate to be reabsorbed (Calvert et al., 1977; Huffman et al., 1972) . Studies of the novel antifolate ZD9331 showed that ZD9331 exhibits saturable renal reabsorption (Goh et al., 2001; Sawyer et al., 2003) . In contrast to the antifolates, renal handling of folic acid has been well described. Although antifolates and folate share a common pathway of renal elimination, the role of renal folate receptors (FRs) has yet to be studied with respect to the antifolates.
Early studies showed that folic acid undergoes saturable renal reabsorption. Goresky et al. (Goresky et al., 1963) showed that, as the plasma levels of folic acid increase, the renal clearance of folic acid also increases. Studies of renal reabsorption of folic acid have identified the presence of tight-binding proteins, the FRs, in renal proximal tubule brush border membranes (Corrocher et al., 1985; Selhub and Rosenberg, 1978) . Renal clearance of folate derivatives was inversely related to the affinity of FRs for folates (McMartin et al., 1981) , suggesting involvement of FRs in renal reabsorption of folates by proximal tubules. Data from primary cultures of human proximal tubule cells (Morshed et al., 1997) 5 mediated uptake was primarily by RFCs. Folate reabsorption was shown to be pH-dependent with a marked reduction at alkaline pH (McMartin et al., 1992) .
The ability of human kidney to reabsorb antifolates via the FRs has not been studied and the effect of changes of pH on antifolate binding to kidney FRs is unknown. We therefore undertook studies of the interactions of folates and antifolates with FRs on human kidney brush border membranes to better understand their role in renal handling of antifolates. We hypothesized that antifolates would bind to brush border membrane vesicles and that this binding would be consistent with involvement of the FRs in their reabsorption. In contrast to the rest of the human body, the renal tubular fluid is acidic with an average pH of 6.0. To approximate normal renal conditions, our studies of antifolate binding to brush border membrane vesicles were carried out at pH 6.0. We expected that the FRs of the proximal tubule would exhibit the highest affinity for the most nephrotoxic antifolate (i.e., CB3717) and the least affinity for the least nephrotoxic antifolate (i.e., methotrexate).
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Tissue source
Normal human kidney cortex from tumor-free regions was obtained from renal cell cancer patients following nephrectomy. The outer capsule, fat and medulla were removed; tissue was cut into small pieces, washed twice with ice-cold solution of phosphate buffer solution (PBS) to remove blood and snap frozen in liquid nitrogen for storage at -80 0 C until use.
Isolation of Brush Border Membrane Vesicles
Brush border membrane vesicles (BBMV) from human kidney cortex were prepared as described earlier (Booth and Kenny, 1974) . The final pellet of each preparation of BBMV was resuspended in an appropriate volume of 300 mM mannitol and 5 mM Tris-HCl buffer pH (7.4), and passed through a fine needle to produce uniform BBMV. All procedures were carried out at 4 0 C. Alkaline phosphatase (EC 3.1.3.1) activity was monitored using the Sigma alkaline phosphatase activity kit as an indicator of enrichment of brush border membranes and protein content was determined with the Bio-Rad protein assay kit. Alkaline phosphatase activity was This article has not been copyedited and formatted. The final version may differ from this version. below were conducted using BBMV prepared from pooled sources.
Determination of pH optimum for folic acid binding
Binding of [ 3 H]folic acid to kidney BBMV was assessed using a filtration assay described previously for collection of radiolabeled membrane vesicles (Agbanyo et al., 1988 
Involvement of FRs in binding
To Prusoff equation (Cheng and Prusoff, 1973) . Thermodynamic stability of the receptor-ligand complexes was estimated from ∆ G 0 as described elsewhere (de Koning and Jarvis, 2001 ).
This article has not been copyedited and formatted. The final version may differ from this version. were examined. Osmotic swelling or shrinkage of membrane vesicles due to lower or higher external osmolarity, respectively, will change the intravesicular volume. BBMV were first incubated for 30 min with binding buffer (pH 6.0) at different osmolarities, followed by addition of 15 nM [ 3 H]folic acid after which the mixtures were incubated for an additional 45 minutes.
The binding activity observed (Fig. 3B ) was independent of external osmotic pressure, indicating that vesicle-associated folic acid was a measure of binding to vesicles rather than accumulation in the intravesicular space. 
Equilibrium binding of folic acid to FRs as a function of pH

Discussion
The kidney has a major role in folate homeostasis. Goresky et al. (Goresky et al., 1963) first showed that folate had non-linear pharmacokinetics, due to active renal reabsorption .
Subsequently Selhub et al. (Selhub and Rosenberg, 1978) showed that kidney proximal tubules possess high-affinity binding proteins for folate on their luminal borders. Ross et al. (Ross et al., 1994) showed that these proteins were the α FRs. Human kidney cells transport folate from apical to basolateral surfaces (McMartin et al., 1992) and transport is pH dependent with a maximum at 6.0.
The antifolates, like natural folates, are eliminated via the kidney (Azarnoff et al., 1974; Beale et al., 1998; Rinaldi et al., 1999; Sessa et al., 1988) . Despite the dominant role of FRs in renal elimination of natural folates, their involvement in the renal elimination of antifolates has not been studied. A new antifolate ZD9331, which cannot be polyglutamated (Jackman et al., 1994) , has raised questions about renal elimination of antifolates (Goh et al., 2001; Sawyer et al., 2000) , since ZD9331 had non-linear pharmacokinetics that appeared to be due to saturable renal reabsorption.
The ZD9331 studies led to the hypothesis that antifolates are being reabsorbed by the FRs that reabsorb natural folates. If renal reabsorption of antifolates is involved in antifolate nephrotoxicity, the hypothesis predicts that affinity of FRs for antifolates will correlate with that tendency of antifolates to cause nephrotoxicity. Our initial experiments were undertaken to optimize conditions for binding of folic acid to BBMV prepared from human kidney cortex.
Binding of folic acid to BBMV was maximal at an acidic pH and changes in medium osmolarity indicated that the observed association of folic acid with BBMV was due to specific binding and not to accumulation mediated by a transport process. Similar results were reported in human This article has not been copyedited and formatted. The final version may differ from this version. Results of studies of renal elimination of antifolates are contradictory. In one study (Monjanel et al., 1979) 12 patients treated with methotrexate were hydrated and their urine alkalinized. Renal elimination of methotrexate exceeded creatinine clearance, suggesting renal secretion. In contrast, Calvert et al. (Calvert et al., 1977) studied renal elimination of methotrexate in 18 patients and found that renal clearance of methotrexate was substantially less than creatinine clearance, suggesting renal reabsorption of methotrexate. Similarly, Huffman et al. (Huffman et al., 1972) , who studied renal elimination of methotrexate in 22 patients, found that methotrexate This article has not been copyedited and formatted. The final version may differ from this version. clearance was less than creatinine clearance, suggesting renal reabsorption. In the studies that showed methotrexate secretion, patients were hydrated and had high urine flow rates, whereas in the studies that showed methotrexate reabsorption, patients were not hydrated. Active reabsorption by FRs could explain the contradiction between the studies. In hydrated patients, urine flow rates would be too high to allow FRs in the proximal tubules time to reabsorb methotrexate, whereas in non-hydrated patients, urine flow rates would be low enough to allow methotrexate reabsorption.
In addition to urine flow rates, changes in proximal tubular pH (e.g., as a result of hydration vs. no hydration), as well as variable folate levels (which in turn compete for the binding sites on FRs) could explain the contradictions in literature on MTX clearance.
There were substantial effects of pH on FR affinities for various folates and antifolates, presence of pH sensitive groups on some antifolates. We speculate that the antifolates that exhibited increased binding to FRs with alkalinization, have pH sensitive groups that either become protonated at low pH and are repulsed out of the binding pocket or become deprotonated at high pH and have enhanced ability to interact with the binding pocket of FRs.
Methotrexate is widely used and its nephrotoxicity is uncommon with current hydration and alkalinization strategies. In contrast, CB3717, despite showing promising antitumor activity, was abandoned due to its unpredictable and frequent nephrotoxicity. We predicted that FRs in the kidney would have the highest and lowest affinities, respectively, for CB3717 and methotrexate of the antifolates tested. We found that the K i value for methotrexate at pH 6.0 was 1290 nM, whereas the K i values for CB3717 and folic acid at pH 6.0 were 0.53 and 0.61 nM, respectively. The K i value for CB3717 was lower than any of the naturally occurring folates for FRs in kidney.
The pharmacology of aminopterin raises questions about decreased solubility and precipitation as a cause of antifolate nephrotoxicity. Aminopterin is more soluble than methotrexate in urine at 37 o C and 10-fold more potent than methotrexate in inhibiting dihydrofolate reductase. Based on the precipitation theory of antifolate nephrotoxicity, aminopterin should be less toxic than methotrexate. Although Glode et al (Glode et al., 1979) predicted that aminopterin would be more efficacious and less nephrotoxic than methotrexate, they found that 50% of patients who received aminopterin without hydration developed doselimiting nephrotoxicity. Two patients who died from renal failure lacked aminopterin precipitates in the kidney at autopsy and these authors suggested that antifolates may cause nephrotoxicity independent of renal precipitation. In contrast, our theory of renal antifolate elimination, predicts that aminopterin would be more nephrotoxic than methotrexate. Renal FRs had higher affinities This article has not been copyedited and formatted. The final version may differ from this version. for aminopterin than for methotrexate at every pH tested. Although hydration and alkalinization decreased aminopterin toxicity (Glode et al., 1979) , the efficacy of hydration alone in decreasing nephrotoxicity was not tested.
Our data on binding of methotrexate to FRs suggest that alkalinization of urine would increase reabsorption of methotrexate if it were not for the increased tubular fluid flow rates associated with hydration. No study has studied the effects of hydration and folic acid supplementation without alkalinizing the urine. Urine alkalinization may have an additional beneficial effect in that alkalinization would improve the solubility of methotrexate and thus prevents its precipitation in renal tubules.
In conclusion, we report pH-dependent interaction of folates and antifolates with FRs on This article has not been copyedited and formatted. The final version may differ from this version. Each data point (mean ± S.E.) was derived from three independent experiments, and where SD values are not shown, values were smaller than the symbols. Table 2 .
